Haraguchi Takuya, Tan Michinao, Uchida Daiki, Dannoura Yutaka, Shibata Tsuyoshi, Iwata Shuko, Azuma Nobuyoshi
Department of Cardiology, Asia Medical Group, Sapporo Heart Center, Sapporo Cardiovascular Clinic, Sapporo, Japan.
Cardiovascular Center, Tokeidai Memorial Hospital, Sapporo, Japan.
Catheter Cardiovasc Interv. 2025 Jan;105(1):211-218. doi: 10.1002/ccd.31319. Epub 2024 Dec 3.
This study aimed to assess the 1-year clinical outcomes and predictors of technical success in acute limb ischemia (ALI) treatment.
A sub-analysis of the REtroSpective multiCenter study of endovascUlar or surgical intErvention for ALI (RESCUE ALI) study involved 185 patients with ALI and technical success (n = 131) or failure (n = 54) treated via surgical, endovascular, or hybrid revascularization between January 2015 and August 2021. The primary endpoint was 1-year amputation-free survival (AFS), and the secondary endpoints included preoperative complications and 1-year reintervention.
The technical success group had a significantly higher 1-year AFS rate than the technical failure group (79% vs. 44%, p < 0.001). Perioperative complications rate showed no significant difference between the two groups. The incidence of reintervention was lower in the technical success group (17% vs. 30%, p = 0.049). Age ≥ 80 years, time from onset ≥ 24 h, no below-the-knee artery runoff, and preoperative c-reactive protein ≥ 5 mg/dL were negatively associated with technical success across all procedures. In surgical revascularization, no below-the-knee artery runoff was negatively associated with technical success. For endovascular revascularization, onset-to-treatment time ≥ 48 h was negatively related and thromboembolism in atrial fibrillation was positively related to technical success. In hybrid revascularization, supra- to infrapopliteal lesions were negatively associated with technical success.
Technical success in ALI treatment significantly enhances 1-year AFS rates. Thus, choosing the appropriate revascularization procedure based on predictors of technical success is crucial for improving patient outcomes.
本研究旨在评估急性肢体缺血(ALI)治疗的1年临床结局及技术成功的预测因素。
对急性肢体缺血血管内或外科干预的回顾性多中心研究(RESCUE ALI)进行亚分析,纳入了2015年1月至2021年8月间通过外科、血管内或杂交血运重建治疗的185例ALI患者,其中技术成功(n = 131)或失败(n = 54)。主要终点为1年无截肢生存率(AFS),次要终点包括术前并发症和1年再次干预。
技术成功组的1年AFS率显著高于技术失败组(79%对44%,p < 0.001)。两组围手术期并发症发生率无显著差异。技术成功组再次干预的发生率较低(17%对30%,p = 0.049)。年龄≥80岁、发病时间≥24小时、无膝下动脉血流、术前C反应蛋白≥5mg/dL与所有手术的技术成功呈负相关。在外科血运重建中,无膝下动脉血流与技术成功呈负相关。对于血管内血运重建,治疗开始时间≥48小时与技术成功呈负相关,房颤中的血栓栓塞与技术成功呈正相关。在杂交血运重建中,腘动脉上至下病变与技术成功呈负相关。
ALI治疗的技术成功显著提高1年AFS率。因此,根据技术成功的预测因素选择合适的血运重建手术对于改善患者结局至关重要。